Reps Porter, Tlaib and Pressley used an Oversight Committee hearing to press the CEOs of Teva, Celgene and Bristol-Myers Squibb on the results of an 18-month investigation into the pricing of two drugs: Teva’s Multiple Sclerosis drug Copaxone and Bristol-Myers Squibb’s Multiple Myeloma drug Revlimid. Continue reading “You just got better at making money” Rep. Katie Porter Accuses Big Pharma